• doceng








ACIST® Medical Systems, a Bracco Group company, develops advanced contrast injection technologies that help simplify the complexities of the cardiac cath lab, hybrid operating room and radiology suite.


Manafacture's Site





 The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.



Manafacture's Site



Since 1982, NuMED has been developing, manufacturing and delivering innovative cardiovascular medical products for the smallest of patients to adults with heart defects.

They provide physicians with the highest quality devices for diagnosing and treating congenital heart disease or compromised peripheral arteries. Many of their products have been designed to respond to the specific needs of doctors, technicians and nurses.



Manafacture's Site












.PLC Systems Inc. is a medical device company focused on innovative technologies for the cardiac and vascular markets.

PLC's lead product, RenalGuard®, significantly reduces the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney injury resulting from toxic contrast agents that occurs in 10% to 20% of at-risk patients. RenalGuard is CE-marked and is being sold in Euorope and certain countries around the world. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. The CIN-RG pivotal study is underway in the U.S. to support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration.


RenalGuard is a closed loop system designed to minimize the risk of over- or under-hydration while maintaining the high urine flows recommended for the prevention of CIN.

Manafacture's Site






Toray Group fuses nanotechnology into its operations, using organic synthetic chemistry, polymer chemistry and biotechnology as its core technologies. In addition to the Foundation Businesses of fibers & textiles and plastics & chemicals, Toray likewise promotes the global development of IT-related products, carbon fiber composite materials, pharmaceuticals and medical products, environment & engineering including water treatment and progress in other pivotal business fields.


 Manafacture's Site

Jump to page content